LMT
Another fund says, “Yep, still in”
Farther Finance Advisors LLC just fattened its Lockheed Martin position by 6,468 shares, a 64.4% jump that took its stake to 16,504 shares worth about $7.98 million at quarter-end. Not exactly a moonshot headline, but for a defense heavyweight like Lockheed, every new institutional buy is basically a tiny endorsement stamp.
The bigger Lockheed backdrop
This filing shows up while Lockheed is juggling a few very investor-friendly moving parts:
- Q4 EPS came in at $5.80, a miss versus the $6.33 estimate
- Revenue hit $20.32 billion, up 9.1% year over year and ahead of expectations
- The company is still paying a chunky quarterly dividend of $3.45, or $13.80 annualized
That’s the classic Lockheed mix: not always dazzling on the earnings line, but sturdy on cash flow, backlog, and government-funded visibility. Kind of the opposite of a flashy growth stock — more “steady contractor with a giant invoice printer.”
Why investors may care
The company also has fresh fuel in the tank from big awards and program wins, including roughly $4.7 billion from the Army, about $4.76 billion tied to PAC-3 production, and up to $1.9 billion for C-130J training. On top of that, Lockheed recently boosted its venture fund to $1 billion, which adds a little strategic optionality without turning it into Silicon Valley cosplay.
Big picture
A single fund buying shares won’t move Lockheed by itself. But paired with strong backlog visibility, fat dividends, and a steady stream of Pentagon spending, it reinforces the idea that LMT is still the kind of stock investors park money in when they want defense, not drama.